GGrantIndex
Sort

39,280 grants matching leukemia

Targeted- and timed-releasing nanotherapeutics against leukemia stem cells

$359,138
Chong-Xian Pan · University Of California At Davis · R01 · FY2017 · CA

Mechanisms of treatment-free remission in a mouse model of chronic myeloid leukemia

$359,138
Richard A. Van Etten · University Of California-Irvine · R01 · FY2025 · CA

BAK Autoactivation in Hematological Malignancies

$359,133
Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2020 · CA

BAK Autoactivation in Hematological Malignancies

$359,133
Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2021 · CA

Activating PTPN11 and c-kit Mutations in Myeloproliferative Disorder

$359,123
Rebecca J Chan · Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2007 · HL

Vascular determinants of sympathetic innervation

$359,123
Deborah Heins Damon · University Of Vermont & St Agric College · R01 · FY2007 · HL

Vascular determinants of sympathetic innervation

$359,123
Deborah Heins Damon · University Of Vermont & St Agric College · R01 · FY2008 · HL

Cell Death Induced by Anticancer Agents

$359,119
Dartmouth College · R01 · FY2005 · CA

Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response

$359,100
Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2024 · CA

Structure/function studies of CTLD NK immunoreceptors

$359,090
Roland K Strong · Fred Hutchinson Cancer Research Center · R01 · FY2009 · AI

The influence of proteostasis loss in aging hematopoietic stem cells on leukemia initiation

$359,056
Robert A.j. Signer · University Of California, San Diego · U01 · FY2022 · CA

Antileukemic effort of NK cells in HCT for pediatric AML

$359,055
Wing Leung · St. Jude Children'S Research Hospital · R01 · FY2007 · CA

HEMATOPOIETIC CELL TRANSPLANTATION FOR MALIGNANCY

$359,000
City Of Hope/Beckman Research Institute · P01 · FY2005 · CA

The Function of Tribbles in the Pathogenesis of AML

$358,982
Warren S Pear · University Of Pennsylvania · P01 · FY2008 · CA

Mechanisms of autoinhibition and activation of the Abl kinase

$358,980
Charalampos Kalodimos · Rutgers, The State Univ Of N.J. · R01 · FY2013 · GM

Cell Grafts for Parkinson's Disease

$358,900
Rush University Medical Center · R01 · FY2001 · NS

The Role of CD5 in B-Cell Development and Autoimmunity

$358,875
Chander Raman · University Of Alabama At Birmingham · R01 · FY2010 · AI

Lymphoma Studies

$358,868
Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA

Targeted- and timed-releasing nanotherapeutics against leukemia stem cells

$358,851
Chong-Xian Pan · University Of California At Davis · R01 · FY2016 · CA

Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis

$358,824
Celine Dermardirossian · San Diego Biomedical Research Institute · R01 · FY2019 · CA

Regulation of IL-6-Type Cytokine Cardioprotective Signaling in the Ischemic Heart

$358,805
George W. Booz · University Of Mississippi Med Ctr · R01 · FY2011 · HL

Novel target for therapy refractory lung tumors

$358,793
Ann Marie Pendergast · Duke University · R01 · FY2015 · CA

MOLECULAR MECHANISMS OF NUCLEIC ACID DAMAGE BY ENEDIYNES

$358,757
Harvard University (Medical School) · R01 · FY2004 · GM

Notch signaling in brain tumors

$358,750
Charles George Eberhart · Johns Hopkins University · R01 · FY2008 · NS

Notch signaling in brain tumors

$358,750
Charles George Eberhart · Johns Hopkins University · R01 · FY2009 · NS